The Max Foundation is a US based NGO at the center of access to treatment for CML in developing countries. The organization is a main partner in the Glivec International Patient Assistance Program (GIPAP) as well as a key element in other treatment access programs, providing services to more than 23,000 CML patients annually. Additionally, The Max Foundation provides services to patient associations, partnering with patient leaders to establish and sponsor local patient groups.